Cardizem SR Tablet (Sustained Release) 90 mg

Cardizem SR Tablet (Sustained Release) 90 mg Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name Cardizem SR Tablet (Sustained Release) 90 mg
Generic Diltiazem Hydrochloride
Weight 90 mg
Type Tablet (Sustained Release)
Therapeutic Class Calcium-channel blockers
Manufacturer Drug International Ltd.
Available Country Bangladesh
Last Updated: October 19, 2023 at 6:27 am
Cardizem SR Tablet (Sustained Release) 90 mg
Cardizem SR Tablet (Sustained Release) 90 mg

Uses

Cardizem SR Tablet (Sustained Release) 90 mg film-coated tablet is used for the prophylaxis and treatment of chronic stable (classical) and vasopastic angina pectoris and has also been used alone or in combination in the management of hypertension, also, Diltiazem is effective in myocardial infarction, coronary artery spasm ... Read more

Dosage

Cardizem SR Tablet (Sustained Release) 90 mg dosage

Film-coated formulation: The usual dose of Cardizem SR Tablet (Sustained Release) 90 mg film coated tablet is 60 mg thrice daily. However patient's response may vary and dosage requirements can differ significantly between individual patients. If necessary, the divided dose may be increased to 180-300 mg/day. Dosage may be started as 30 mg four times daily and increasing at 1 to 2 days intervals until the optimum response is achieved. Higher doses upto 480 mg/day have been used with benefit in some patients especially in unstable angina. Elderly and patients with impaired hepatic or renal function: The recommended starting dose is 60 mg twice daily. The heart rate should be measured regularly and the dose should not be increased if the heart rate falls below 50 beats per minute.Sustained release formulation: Mild to moderate hypertension: initially 90 mg or 120 mg twice daily (elderly once daily); up to 360 mg daily may be required (elderly upto 240 mg) daily. Angina: initially 90 mg or 120 mg twice daily in divided doses may be required (elderly up to 240 mg daily).

Side Effects

Bradycardia, sino-atrial block, atrioventricular block, hypertension, malaise, headache, hot flushes, GIT disturbances, oedema, hepatitis and depression reported.

Interaction

Concomitant prophylactic therapy with short-or long-acting nitrates may be administered safely during diltiazem therapy. Diltiazem recommended caution and careful dosage titration when diltiazem is administered concomitantly with other drugs that can affect cardiac contractility and/ or conduction.

Pregnancy & Breastfeeding use

There are no adequate and controlled studies to date with diltiazem in pregnant women, and the drug should be used during pregnancy only when the potential benefits justify the possible risk to the fetus. Because diltiazem is distributed into milk, women receiving the drug should not breastfeed their infants; an alternative method of infant feeding should be used if diltiazem therapy is considered necessary in nursing women.

Contraindication

Cardizem SR Tablet (Sustained Release) 90 mg sustained release tablet is contraindicated in patients with known hypersensitivity to the drug, sick sinus syndrome, second or third degree AV block, severe hypertension or acute myocardial infarction and rediographically documented pulmonary congestion.

Storage Condition

Keep medicine out of the reach of children. Store in a cool and dry place.

Innovators Monograph

You find simplified version here Cardizem SR Tablet (Sustained Release) 90 mg


*** Taking medicines without doctor's advice can cause long-term problems.
Share